Sign in

CIK 0001642380

  • Non-accelerated filer
  • Smaller reporting company

Insight Molecular Diagnostics Inc.

Sign in to watch
Ticker
IMDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
271041563
Phone
+1 949-409-7600
Business address
2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
Former names
OncoCyte Corp, Oncocyte Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 23 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-05-23 HESTERBERG LYNDAL K. Sr VP, Research & Development Grant or award · Option to Purchase Common Stock +150,000 150,000
2018-05-23 Levine Mitchell S Chief Financial Officer Grant or award · Option to Purchase Common Stock +50,000 50,000
2018-05-23 Levine Mitchell S Chief Financial Officer Grant or award · Option to Purchase Common Stock +125,000 125,000

Page 20 of 20 · 383 trades